Case Study: More Than Headache Relief: What Kids Told Us About Migraine Treatment

A light blue neuron against a dark blue background

The Challenge

Following a successful new adult migraine therapy, a pharmaceutical
company wanted to launch a series of pediatric trials. But traditional
recruitment methods were seeing extremely high screen failure rates and
slow enrollment.

The PreMatch360 Solution

The DCRI team created a cohort of clinically phenotyped children with migraine, ready for trial activation. We leveraged our network of community partners to engage with families and patients across multiple touchpoints. Patient preferences helped us shape a participant-friendly protocol.

Why It Matters

PreMatch360 quickly delivered eligible, engaged participants and facilitating downstream trial performance.

Impact

Pre-screened cohort delivered to 10 academic and community-based research sites.


200 trial-ready participants enrolled


3 peer-reviewed publications (1, 2, 3)


Patient insights that shaped protocol design and retention strategies

Headache. 2020 Feb;60(2):405-415. Pediatr Neurol. 2023 Sep:146:79-84.

Ready for smoother, faster, more successful trials?